Uncategorized

Oberland pours up to $400M into MeiraGTx eye gene therapies

Published

on

The funding deal is a vote of confidence in the sales potential of multiple prospects in late-stage development — one of which MeiraGTx recently reacquired from J&J. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version